These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 479378)

  • 21. Heparin therapy.
    Korst DR; Raich PC
    Wis Med J; 1972 Jul; 71(7):188-90. PubMed ID: 5040595
    [No Abstract]   [Full Text] [Related]  

  • 22. Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction.
    Sleight P; Eikelboom JW; Bassand JP
    N Engl J Med; 2006 Jun; 354(26):2830-1; author reply 2831-2. PubMed ID: 16810777
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparin.
    Jaques LB
    New Istanbul Contrib Clin Sci; 1973 Oct; 10(4):208-21. PubMed ID: 4132870
    [No Abstract]   [Full Text] [Related]  

  • 24. Heparin and Heparin-Derivatives in Post-Subarachnoid Hemorrhage Brain Injury: A Multimodal Therapy for a Multimodal Disease.
    Hayman EG; Patel AP; James RF; Simard JM
    Molecules; 2017 May; 22(5):. PubMed ID: 28468328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
    Greaves M;
    Thromb Haemost; 2002 Jan; 87(1):163-4. PubMed ID: 11848446
    [No Abstract]   [Full Text] [Related]  

  • 26. Fatal muscle haemorrhage attributable to heparin administration in a patient with dermatomyositis.
    Higashi Y; Mera K; Kanzaki T; Kanekura T
    Clin Exp Dermatol; 2009 Apr; 34(3):448-9. PubMed ID: 19309387
    [No Abstract]   [Full Text] [Related]  

  • 27. An alternative view of heparin anticoagulation in acute focal brain ischemia.
    Phillips SJ
    Stroke; 1989 Feb; 20(2):295-8. PubMed ID: 2645694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heparins of different molecular weights: biological activity and hemorrhagic risk].
    Cofrancesco E; Pogliani EM
    Recenti Prog Med; 1987; 78(7-8):328-31. PubMed ID: 3321255
    [No Abstract]   [Full Text] [Related]  

  • 29. [Accidents caused by anticoagulants].
    Gruel Y; Maakaroun A
    Rev Prat; 2002 Nov; 52(17):1929-35. PubMed ID: 12532872
    [No Abstract]   [Full Text] [Related]  

  • 30. Managing the hemorrhagic complications of heparin therapy.
    Penner JA
    Hematol Oncol Clin North Am; 1993 Dec; 7(6):1281-9. PubMed ID: 8294317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New data on the pharmacology of heparin and low molecular weight heparins.
    Samama MM; Bara L; Gouin-Thibault I
    Drugs; 1996; 52 Suppl 7():8-14; discussion 14-5. PubMed ID: 9042555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin: applications and future prospects.
    Quick D; Trowbridge AA
    Chest; 1985 Nov; 88(5):755-7. PubMed ID: 4053718
    [No Abstract]   [Full Text] [Related]  

  • 33. Guidelines for heparin therapy.
    Genton E
    Ann Intern Med; 1974 Jan; 80(1):77-82. PubMed ID: 4589514
    [No Abstract]   [Full Text] [Related]  

  • 34. [SOME ANTICOAGULANT PROPERTIES OF THE ARTERIAL WALL].
    DONNER L; HEYROVSKY A
    Thromb Diath Haemorrh; 1964 Jul; 11():476-84. PubMed ID: 14191725
    [No Abstract]   [Full Text] [Related]  

  • 35. [Heparin and its metamorphoses].
    Choay J
    Nouv Rev Fr Hematol (1978); 1981; 23(5):253-6. PubMed ID: 7329802
    [No Abstract]   [Full Text] [Related]  

  • 36. Approaches to prevent bleeding associated with anticoagulants: current status and recent developments.
    Kalathottukaren MT; Haynes CA; Kizhakkedathu JN
    Drug Deliv Transl Res; 2018 Aug; 8(4):928-944. PubMed ID: 28741113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New data on heparin (a review)].
    Bychkov SM
    Vopr Med Khim; 1981; 27(6):726-36. PubMed ID: 7039095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacology of heparin].
    Hoffmann A; Markwardt F
    Z Gesamte Inn Med; 1979 Jan; 34(1):3-8. PubMed ID: 373277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
    Hirsh J; Dalen JE; Deykin D; Poller L
    Chest; 1992 Oct; 102(4 Suppl):337S-351S. PubMed ID: 1327666
    [No Abstract]   [Full Text] [Related]  

  • 40. Uronic acid composition of heparins and heparan sulfates.
    Taylor RL; Shively JE; Conrad HE; Cifonelli JA
    Biochemistry; 1973 Sep; 12(19):3633-7. PubMed ID: 4788306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.